相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treating Hyperuricemia: The Last Word Hasn't Been Said Yet
Elisa Russo et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial
Austin G. Stack et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits
Giovanna Leoncini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Erik J. M. van Bommel et al.
KIDNEY INTERNATIONAL (2020)
Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes
JingWei Li et al.
KIDNEY INTERNATIONAL (2020)
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
A. Doria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Sunil V. Badve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Increased urinary glucose excretion is associated with a reduced risk of hyperuricaemia
J. Chen et al.
DIABETIC MEDICINE (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
Yuka Sato et al.
NATURE REVIEWS NEPHROLOGY (2019)
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker et al.
LANCET (2019)
SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1
Aleksandra Novikov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
Richard J. Johnson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Association between urinary sodium excretion and uric acid, and its interaction on the risk of prehypertension among Chinese young adults
Yang Wang et al.
SCIENTIFIC REPORTS (2018)
Human Mutations in SLC2A9 (Glut9) Affect Transport Capacity for Urate
Anne Ruiz et al.
FRONTIERS IN PHYSIOLOGY (2018)
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta-analysis of randomized controlled trials
Yumo Zhao et al.
DIABETES OBESITY & METABOLISM (2018)
Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2
Daigo Toyoki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome
Erik J. M. van Bommel et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications
Hiddo J. L. Heerspink et al.
CIRCULATION (2016)
Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus
Yuliya Lytvyn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
Yukihiro Chino et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2014)
Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease
Eun-Sun Ryu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
Alexandru Bobulescu et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2012)
Uric Acid Induces Renal Inflammation via Activating Tubular NF-κB Signaling Pathway
Yang Zhou et al.
PLOS ONE (2012)
Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese
K. Ichida et al.
CLINICAL GENETICS (2008)
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans
Naohiko Anzai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Essential hypertension, progressive renal disease, and uric acid:: A pathogenetic link?
RJ Johnson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia
N Wakida et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats
LG Sanchez-Lozada et al.
KIDNEY INTERNATIONAL (2005)
Hyperuricemia induces a primary renal arteriolapathy in rats by a blood pressure-independent mechanism
M Mazzali et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
分享论文
